SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays

BACKGROUND: Studies evaluating neutralizing antibody (NAb) after BNT162b2 vaccine are scarce. We therefore compared NAb using the plaque reduction neutralization test (PRNT) in vaccinated subjects, with those from five chemiluminescent (CLIA) assays, two targeting ACE and S-RBD interaction. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Padoan, Andrea, Cosma, Chiara, Bonfante, Francesco, Rocca, Foscarina della, Barbaro, Francesco, Santarossa, Claudia, Dall'Olmo, Luigi, Pagliari, Matteo, Bortolami, Alessio, Cattelan, Annamaria, Cianci, Vito, Basso, Daniela, Plebani, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553360/
https://www.ncbi.nlm.nih.gov/pubmed/34755646
http://dx.doi.org/10.1016/j.cca.2021.10.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553360/
https://www.ncbi.nlm.nih.gov/pubmed/34755646
http://dx.doi.org/10.1016/j.cca.2021.10.028

Ejemplares similares